Cumberland Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Cumberland Pharmaceuticals's balance sheet done over the years? Its assets were worth $81,776,075 last year, which is less than in the previous period. 64% of Cumberland Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $52,516,206, which means an decrease by -8% compared compared to last year.
Debt to Assets
| 2014 | 95405114 | 14.65M | 15.36% |
|---|---|---|---|
| 2015 | 91918959 | 15.09M | 16.43% |
| 2016 | 93404566 | 20.28M | 21.72% |
| 2017 | 93232312 | 29.31M | 31.44% |
| 2018 | 112693868 | 57.12M | 50.69% |
| 2019 | 104549283 | 53.46M | 51.14% |
| 2020 | 96463305 | 49.58M | 51.41% |
| 2021 | 84459798 | 41.85M | 49.56% |
| 2022 | 92925158 | 56.95M | 61.29% |
| 2023 | 81776075 | 52.51M | 64.22% |
CPIX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 18.32M | 19.75M | 27.04M | 24.75M | 28.21M | 27.93M | 45.41M | 34.51M | 38.20M | 39.86M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 8.29M | 4.67M | 15.62M | 14.56M | 14.84M |
Net receivables | 9.75M | 13.16M | 6.87M | 12.37M | 7.85M | 7.84M | 8.39M | 7.33M | 6.07M | 5.50M |
Inventory | 4.60M | 9.39M | 8.42M | 10.63M | 8.87M | 27.82M | 6.73M | 5.37M | 4.27M | 5.60M |
Other current assets | 3.02M | 3.54M | 3.33M | 2.19M | 2.75M | 2.96M | 3.46M | 2.71M | 3.99M | 5.00M |
Total current assets | 35.71M | 45.87M | 45.68M | 49.96M | 50.16M | 74.86M | 68.68M | 65.54M | 67.11M | 70.81M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 7.04M | 5.50M | 1.46M | 2.60M | 3.70M | 771.21K | 528.88K | 464.45K | 536.45K | 651.03K |
Goodwill | 914K | 914K | 882K | 882K | 882K | 784K | 0 | 0 | 0 | 0 |
Intangible assets | 22.60M | 30.59M | 23.95M | 28.11M | 30.92M | 33.65M | 21.44M | 22.15M | 21.16M | 21.56M |
Long term investments | 0 | 0 | 0 | -662.01K | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 15.49M | 10.04M | 12.46M | 14.89M | 18.85M | 2.53M | 2.48M | 2.12M | 1.89M | 1.79M |
Total non-current assets | 46.06M | 47.05M | 38.77M | 46.49M | 54.38M | 37.82M | 24.54M | 27.85M | 24.80M | 24.59M |
Total assets | 81.77M | 92.92M | 84.45M | 96.46M | 104.54M | 112.69M | 93.23M | 93.40M | 91.91M | 95.40M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 5.49M | 0 | 0 | 0 | 0 | 0 |
Short term debt | 348.09K | 172.91K | 969.67K | 1.01M | 920.43K | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 27.98M | 28.57M | 19.27M | 25.66M | 24.15M | 27.80M | 17.69M | 14.79M | 12.41M | 13.74M |
| Non-current liabilities: | ||||||||||
Long term debt | 18.08M | 20.78M | 15.09M | 16.05M | 20.57M | 20M | 9.8M | 4.1M | 1.7M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 6.45M | 7.58M | 7.48M | 4.49M | 5.14M | 9.31M | 1.81M | -1.84M | 987.42K | 902.84K |
Total non-current liabilities | 24.53M | 28.37M | 22.57M | 23.92M | 29.31M | 29.31M | 11.61M | 5.49M | 2.68M | 902.84K |
Total liabilities | 52.51M | 56.95M | 41.85M | 49.58M | 53.46M | 57.12M | 29.31M | 20.28M | 15.09M | 14.65M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |